GLP-1 Side Effects: What to Watch For

Written by the Sakura Skin team. Medically reviewed by Bethany S. Campbell, JD, RN, Sakura Skin Medical Spa, Fenton & Flint, MI. Published August 28, 2026. Last updated August 28, 2026.

Short answer: Nausea gets all the attention, but the side effects that actually send people back to their provider are constipation, fatigue, reflux, and muscle loss from eating too little protein. Most are manageable with dose pacing, hydration, and food adjustments. The ones that need a call right away are severe abdominal pain radiating to the back, persistent vomiting, or signs of gallbladder trouble.

GLP-1 medications have changed the treatment landscape for type 2 diabetes and obesity—but nausea is not the only side effect worth knowing about. Drugs such as semaglutide, liraglutide, and tirzepatide can affect digestion, blood sugar, hydration, the gallbladder, and more. Understanding what is common, what may improve, and what requires prompt medical attention can help you use these medications more safely.

Common GLP-1 Side Effects Besides Nausea

GLP-1 receptor agonists slow stomach emptying, reduce appetite, and influence blood sugar regulation. These effects can cause several symptoms, especially after starting treatment or increasing the dose.

Vomiting and Diarrhea

Vomiting and diarrhea are among the most frequently reported side effects. In clinical trials of semaglutide for chronic weight management, diarrhea occurred in about 30% of adults and vomiting in about 24%, although rates vary by medication, dose, and patient population. These symptoms can lead to dehydration. Sip fluids regularly, and contact your healthcare professional if you cannot keep liquids down, have very dark urine, or urinate much less than usual.

Constipation

Constipation may develop because GLP-1 medications slow gastrointestinal movement. Helpful measures may include:

• Drinking adequate fluids, unless a clinician has restricted your intake
• Increasing fiber gradually
• Staying physically active
• Asking your healthcare professional whether a stool softener or other treatment is appropriate

Severe constipation, increasing abdominal swelling, or an inability to pass stool or gas should be assessed promptly.

Abdominal Pain, Bloating, and Indigestion

Abdominal pain, bloating, belching, acid reflux, and indigestion can occur. Eating smaller meals, limiting high-fat foods, and avoiding overeating may reduce symptoms. Persistent or severe abdominal pain should not be dismissed as a routine medication effect.

Less Common but Important GLP-1 Risks

Some side effects are less frequent but may signal a medical problem. The risks differ among products, so always review the prescribing information for your specific medication.

Gallbladder Problems

Rapid weight loss and GLP-1 treatment may increase the risk of gallstones or gallbladder inflammation. Warning signs include:

• Sudden pain in the upper right or upper middle abdomen
• Pain that may spread to the back or right shoulder
• Fever
• Yellowing of the skin or eyes
• Pale stools or unusually dark urine

These symptoms warrant prompt medical evaluation. The [FDA prescribing information for Wegovy](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s011lbl.pdf), for example, includes warnings about acute gallbladder disease.

Pancreatitis

Pancreatitis, or inflammation of the pancreas, is uncommon but potentially serious. Seek urgent medical care for severe, persistent abdominal pain—especially pain that radiates to the back—with or without vomiting. Do not restart a GLP-1 medication after suspected pancreatitis unless your prescriber specifically advises you to do so.

Dehydration and Kidney Problems

Vomiting, diarrhea, and reduced fluid intake can cause dehydration. In some cases, dehydration has contributed to worsening kidney function or acute kidney injury, particularly in people with existing kidney disease or those taking medicines that affect the kidneys. Call your healthcare professional if you experience persistent gastrointestinal symptoms, dizziness, fainting, confusion, or a major reduction in urination.

Low Blood Sugar

GLP-1 medications generally have a low risk of hypoglycemia when used alone. The risk rises when they are combined with insulin or sulfonylureas such as glipizide or glyburide. Symptoms of low blood sugar may include:

• Shakiness or sweating
• Hunger
• Fast heartbeat
• Dizziness or weakness
• Confusion or difficulty concentrating
• Blurred vision

People taking combination diabetes therapy may need blood sugar monitoring or medication adjustments. Severe confusion, seizures, or loss of consciousness is an emergency.

Headache, Dizziness, and Fatigue

Headache, dizziness, and tiredness can occur, particularly during dose escalation or when a person is eating and drinking substantially less. These symptoms may also reflect dehydration or low blood sugar, so recurring or severe symptoms deserve medical review.

Injection-Site Reactions and Allergic Reactions

Redness, itching, swelling, or discomfort at the injection site is usually mild and temporary. Rotate injection sites according to the product instructions. Get emergency help for signs of a serious allergic reaction, including facial or throat swelling, trouble breathing, widespread hives, severe dizziness, or fainting.

Rare or Serious Warnings to Know

Changes in Diabetic Retinopathy

Rapid improvements in blood sugar may temporarily worsen diabetic retinopathy in some people, especially those with pre-existing eye disease. Semaglutide labeling advises monitoring people with a history of diabetic retinopathy. Report new or worsening blurred vision, spots, flashes, or other vision changes to your healthcare professional promptly.

Delayed Stomach Emptying and Severe Gastrointestinal Symptoms

Because GLP-1 drugs slow gastric emptying, some people may develop severe or persistent gastrointestinal symptoms. The FDA has also received postmarketing reports of ileus, a condition in which intestinal movement becomes severely impaired. Tell your surgeon and anesthesia team that you take a GLP-1 medication before a procedure. Delayed stomach emptying may affect anesthesia planning, and guidance can vary based on the medication, dose, and individual risk.

Thyroid Tumor Warning

Semaglutide, liraglutide, and tirzepatide products carry a boxed warning about thyroid C-cell tumors based on findings in rodents. It is not known whether these medications cause this type of tumor in humans. They should not be used by people with a personal or family history of medullary thyroid carcinoma or by people with multiple endocrine neoplasia syndrome type 2. Report a neck lump, persistent hoarseness, trouble swallowing, or shortness of breath to a clinician.

When to Contact a Healthcare Professional

Contact your prescriber soon if you have:

• Ongoing vomiting, diarrhea, or constipation
• Difficulty eating or drinking enough
• Symptoms of dehydration
• Repeated low blood sugar readings
• New or worsening vision changes
• Side effects that interfere with daily activities
• Questions about increasing, delaying, or stopping a dose

Seek emergency care for severe abdominal pain, trouble breathing, facial or throat swelling, fainting, seizures, or signs of shock.

How to Reduce GLP-1 Side Effects

Many side effects are more likely during dose increases. Practical strategies include:

1. Follow the prescribed titration schedule rather than increasing the dose early.
2. Eat smaller portions and stop when you feel full.
3. Choose lower-fat meals when gastrointestinal symptoms are active.
4. Drink fluids consistently throughout the day.
5. Keep a record of symptoms, food intake, blood sugar readings, and injection timing.
6. Review all medicines and supplements with your prescriber or pharmacist.
7. Never share injection pens, needles, or compounded medication unless it has been prescribed and dispensed specifically for you.

Do not stop a diabetes or weight-management medication without medical guidance. A clinician may slow dose escalation, adjust another medication, or recommend a different treatment.

The Bottom Line

Nausea is only one possible GLP-1 side effect. Vomiting, diarrhea, constipation, abdominal discomfort, dehydration, low blood sugar, gallbladder disease, pancreatitis, vision changes, and allergic reactions are also important to recognize. Most mild symptoms improve as the body adjusts, but severe, persistent, or unusual symptoms should be evaluated. Read the medication guide for your specific product and contact your healthcare professional whenever you are unsure. For additional details, consult the [FDA medication guides and prescribing information](https://www.fda.gov/drugs/drug-safety-and-availability) and the [National Institute of Diabetes and Digestive and Kidney Diseases](https://www.niddk.nih.gov/health-information/diabetes/overview/insulin-medicines-treatments/other-injectables).

Having Side Effects? Tell Us.

Sakura Skin is a physician-led medical spa with locations at 13389 Pomona Drive in Fenton, MI and 2335 S. Linden Road, Suite B in Flint, MI. We care for GLP-1 patients through our medical weight loss program, serving Genesee and Livingston counties, including Fenton, Flint, Linden, Holly, Grand Blanc, Swartz Creek, Davison, and Hartland.

Do not white-knuckle a side effect you could fix. Slowing your titration, adjusting your dose, treating the symptom directly, or switching medications are all real options. If nausea is your main issue, we cover it in detail in how to relieve nausea on Tirzepatide, and the differences between the two medications in Tirzepatide vs. Semaglutide.

Not feeling right? Call 810-394-2187 or Text 810-512-2496 — or book online at calendly.com/sakuraskin. We’re in Fenton and Flint, MI.

Individual results vary. GLP-1 medications are prescription treatments; dosing and side effect management are determined by your medical provider. Seek urgent medical care for severe abdominal pain, persistent vomiting, or signs of an allergic reaction. This article is for general information and is not medical advice.